Guidelines on CMV congenital infection

Journal of Perinatal Medicine

Volumn 37, Issue 5, 2009, Pages 433-445

  Coll, Oriol ^a   Benoist, Guillaume ^b   Ville, Yves ^b   Weisman, Leonard E ^c   Botet, Francesc ^a   Anceschi, Maurizio ^d   Greenough, Anne ^e   Gibbs, Ronald S ^f   Carbonell Estrany, Xavier ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c TEXAS CHILDREN S HOSPITAL   (United States)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^f UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Amniotic fluid (AF); Congenital cytomegalovirus (CMV); Polymerase chain reaction (PCR)

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; CIDOFOVIR; CYTOMEGALOVIRUS VACCINE; FOSCARNET; GANCICLOVIR; HYPERIMMUNE GLOBULIN; VALACICLOVIR;

ABSENCE OF SIDE EFFECTS; AMNIOCENTESIS; BRAIN DAMAGE; CLINICAL TRIAL; CONGENITAL INFECTION; COUNSELING; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC VALUE; DISEASE TRANSMISSION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS BLOOD SAMPLING; FOLLOW UP; HEALTH EDUCATION; HEARING IMPAIRMENT; HIGH RISK PATIENT; HUMAN; INCONTINENTIA PIGMENTI; INTRAUTERINE INFECTION; LABORATORY TEST; MICROCEPHALY; NEUTROPENIA; NEWBORN SCREENING; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PREGNANCY TERMINATION; PREGNANT WOMAN; PRENATAL DIAGNOSIS; PRIMARY INFECTION; PRIORITY JOURNAL; PROGNOSIS; REINFECTION; REVIEW; RISK FACTOR; SCREENING TEST; SECONDARY INFECTION; SEROCONVERSION; SEROPREVALENCE; TREATMENT OUTCOME; ULTRASOUND; UNILATERAL HEARING LOSS; URINALYSIS; VERTICAL TRANSMISSION; VIRUS DETECTION;

ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FETAL DISEASES; GESTATIONAL AGE; HUMANS; IMMUNOGLOBULINS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTORS;

EID: 70349448519     PISSN: 03005577     EISSN: 16193997     Source Type: Journal    
DOI: 10.1515/JPM.2009.127     Document Type: Review

References (111)

1. Ahlfors K, Ivarsson SA, Johnsson T, Svanberg L. Primary and secondary maternal cytomegalovirus infections and their relation to congenital infection. Analysis of maternal sera. Acta Paediatr Scand. 1982;71:109-113
2. Ahlfors K, Forsgren M, Ivarsson SA, Harris S, Svanberg L. Congenital cytomegalovirus infection: on the relation between type and time of maternal infection and infant's symptoms. Scand J Infect Dis. 1983;15:129-138
3. Ahlfors K, Ivarsson SA, Harris S, Svanberg L, Holmqvist R, Lernmark B, et al. Congenital cytomegalovirus infection and disease in Sweden and the relative importance of primary and secondary maternal infections. Preliminary findings from a prospective study. Scand J Infect Dis. 1984;16:129-137
4. Ahlfors K, Ivarsson SA, Harris S. Secondary maternal cytomegalovirus infection - A significant cause of congenital disease. Pediatrics. 2001;107:1227-1228
5. Anderson KS, Amos CS, Boppana S, Pass R. Ocular abnormalities in congenital cytomegalovirus infection. J Am Optom Assoc. 1996;67:273-278
6. Arvin AM, Fast P, Myers M, Plotkin S, Rabinovich R. Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee. Clin Infect Dis. 2004;39:233-239
7. Baccard-Longere M, Freymuth F, Cointe D, Seigneurin JM, Grangeot-Keros L. Multicenter evaluation of a rapid and convenient method for determination of cytomegalovirus immunoglobulin G avidity. Clin Diagn Lab Immunol. 2001;8:429-431
8. Barbi M, Binda S, Caroppo S, Primache V, Dido P, Guidotti P, et al. CMV gB genotypes and outcome of vertical transmission: study on dried blood spots of congenitally infected babies. J Clin Virol. 2001;21:75-79
9. Barbi M, Binda S, Primache V, Caroppo S, DidòP, Guidotti P, et al. Cytomegalovirus DNA detection in Guthrie cards: a powerful tool for diagnosing congenital infection. J Clin Virol. 2000;17:159-165
10. Benoist G, Salomon LJ, Jacquemard F, Daffos F, Ville Y. The prognostic value of ultrasound abnormalities and biological parameters in blood of fetuses infected with cytomegalovirus. Br J Obstet Gynaecol. 2008;115:823-829
11. Benshushan A, Brezenzinki A, Ben-David A, Nadjari M. Early recurrent CMV infection with severe outcome to the fetus. Acta Obstet Gynecol Scand. 1998;7:694-695
12. Bhide A, Papageorghiou AT. Managing primary CMV infection in pregnancy. Br J Obstet Gynaecol. 2008;115: 805-807
13. Bissinger AL, Sinzger C, Kaiserling E, Jahn G. Human cytomegalovirus as a direct pathogen: correlation of multiorgan involvement and cell distribution with clinical and pathological findings in a case of congenital inclusion disease. J Med Virol. 2002;67:200-206
14. Bodeus M, Hubinnont C, Goubau P. Increased risk of cytomegalovirus transmission in-utero during late gestation. Obstet Gynecol. 1999;93:658-660
15. Bodeus M, Hubinont C, Goubau P. Increased risk of cytomegalovirus transmission in utero during late gestation. Obstet Gynecol. 1999;93:658-660
16. Boppana SB, Pass RF, Britt WJ, Stagno S, Alford CA. Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr Infect Dis J. 1992; 11:93-99
17. Boppana SB, Fowler KB, Britt WJ, Stagno S, Pass RF. Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus. Pediatrics. 1999;104:55-60.
18. Burny W, Liesnard C, Donner C, Marchant A. Epidemiology, pathogenesis and prevention of congenital cytomegalovirus infection. Expert Rev Anti Infect Ther. 2004; 2:881-894
19. Cannon MJ, Davis KF. Washing our hands of the congenital cytomegalovirus disease epidemic. BMC Public Health. 2005;5:70.
20. Chandler SH, Alexander ER, Holmes KK. Epidemiology of cytomegaloviral infection in a heterogeneous population of pregnant women. J Infect Dis. 1985;152:249-256
21. Daiminger A, Bäder U, Enders G. Pre- and periconceptional primary cytomegalovirus infection: risk of vertical transmission and congenital disease. Br J Obstet Gynaecol. 2005;112:166-172
22. Demmler GJ. Congenital cytomegalovirus infection. Semin Pediatr Neurol. 1994;1:36-42.
23. Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol. 2007;17:355-363
24. Donner C, Liesnard C, Brancart F, Rodesch F. Accuracy of amniotic fluid testing before 21 weeks' gestation in prenatal diagnosis of congenital cytomegalovirus infection. Prenat Diagn. 2004;14:1055-1059
25. Eggers M, Metzger C, Enders G. Differentiation between acute primary and recurrent human cytomegalovirus infection in pregnancy, using a microneutralization assay. J Med Virol. 1998;56:351-358
26. Eggers M, Bader U, Enders G. Combination of microneutralization and avidity assays: improved diagnosis of recent primary human cytomegalovirus infection in single serum sample of second trimester pregnancy. J Med Virol. 2000;60:324-330
27. Enders G, Bäder U, Lindemann L, Schalasta G, Daiminger A. Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome. Prenat Diagn. 2001;21:362-377
28. Fowler KB, Stagno S, Pass RF, Britt WJ, Boll TJ, Alford CA. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med. 1992;326:663-667
29. Fowler KB, Dahle AJ, Boppana SB, Pass RF. Newborn hearing screening: will children with hearing loss caused by congenital cytomegalovirus infection be missed? J Pediatr. 1999;135:60-64
30. Fowler KB, Stangno S, Pass RF. Maternal immunity and prevention of congenital cytomegalovirus infection. J Am Med Assoc. 2003;289:1008-1011
31. Gaytant MA, Rours JR, Steengers AP, Galama J, Semmekrot BA. Congenital cytomegalovirus infection after recurrent infection: case reports and review of the literature. Eur J Pediatr. 2003;162:248-253
32. Gindes L, Teperberg-Oikawa M, Sherman D, Pardo J, Rahav G. Congenital cytomegalovirus infection following primary maternal infection in the third trimester. Br J Obstet Gynaecol. 2008;115:830-835
33. Gouarin S, Gault E, Vabret A, Cointe D, Rozenberg F, Grangeot-Keros L, et al. PCR quantification of human cytomegalovirus DNA in amniotic fluid samples from mothers with primary infection. J Clin Microbiol. 2002; 1767-1772
34. Grangeot-Keros L, Mayaux MJ, Lebon P, Freymuth F, Eugene G, Stricker R, et al. Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women. J Infect Dis. 1997;175:944-946
35. Grangeot-Keros L, Simon B, Audibert F, Vial M. Should we routinely screen for cytomegalovirus antibody during pregnancy? Intervirology. 1998;41:158-162
36. Gratacap-Cavallier B, Morand P, Dutertre N, Bosson JL, Baccard-Longère M, Jouk PS, et al. Cytomegalovirus infection in pregnant women. Seroepidemiological prospective study in 1,018 women in Isere. J Gynecol Obstet Biol Reprod (Paris). 1998;27:161-166
37. Griffiths PD, Campbell-Benzie A, Heath RB. A prospective study of primary cytomegalovirus infection in pregnant women. Br J Obstet Gynaecol. 1980;87:308-314
38. Guerra B, Lazzarotto T, Quarta S, Lanari M, Bovicelli L, Nicolosi A, et al. Prenatal diagnosis of symptomatic congenital cytomegalovirus infection. Am J Obstet Gynecol. 2000;183:476-482 (Pubitemid 30651101)
39. Guerra B, Simonazzi G, Banfi A, Lazzarotto T, Farina A, Lanari M, et al. Impact of diagnostic and confirmatory tests and prenatal counseling on the rate of pregnancy termination among women with positive cytomegalovirus immunoglobulin M antibody titers. Am J Obstet Gynecol. 2007;196:221e1-6
40. Guerra B, Simonazzi G, Puccetti C, Lanari M, Farina A, Lazzarotto T, et al. Ultrasound prediction of symptomatic congenital cytomegalovirus infection. Am J Obstet Gynecol. 2008;198:380.e1-7
41. Guerra B, Simonazzi G, Puccetti C, Lanari M, Farina A, Lazzarotto T, et al. Ultrasound prediction of symptomatic congenital cytomegalovirus infection. Am J Obstet Gynecol. 2008;198:380.e1-7
42. Henrich W, Meckies J, Dudenhausen JW, Vogel M, Enders G. Recurrent cytomegalovirus infection during pregnancy: ultrasonographic diagnosis and fetal outcome. Ultrasound Obstet Gynecol. 2002;19:608-611
43. Hodson EM, Jones CA, Strippoli GF, Webster AC, Craig JC. Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database Syst Rev. 2007;2.
44. Jacquemard FYM, Picone O, Costa JM, Romand S, Jacz-Aigrain E, Daffos F, et al. Cytomegalovirus intrauterine infection: pharmacokinetics of valacyclovir administration to the mother and changes in DNA viral load in amniotic fluid and fetal blood. Br J Obstet Gynaecol. 2007;114:1113-1121
45. Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol. 2007;17:253-276
46. Kimberlin DW, Lin CY, Sánchez PJ, Demmler G, Dankner W, Shelton M, et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr. 2003;143:16-25.
47. Kimberlin DW, Acosta EP, Sánchez PJ, Sood S, Agrawal V, Homans J, et al. Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease. J Infect Dis. 2008;197:836-845
48. Kumar ML, Nankervis GA, Jacobs IB, Ernhart CB, Glasson CE, McMillan PM, et al. Congenital and postnatally acquired cytomegalovirus infections: long-term followup. J Pediatr. 1984;104:674-679
49. La Torre R, Nigro G, Mazzocco M, Best AM, Adler SP. Placental enlargement in women with primary maternal cytomegalovirus infection is associated with fetal and neonatal disease. Clin Infect Dis. 2006;43:994-1000.
50. Lagasse N, Dhooge I, Govaert P. Congenital CMV - infection and hearing loss. Acta Otorhinolaryngol Belg. 2000;54:431-436
51. Lazzarotto T, Brojanac S, Maine GT, Landini MP. Search for cytomegalovirus-specific immunoglobulin M: comparison between a new western blot, conventional western blot, and nine commercially available assays. Clin Diagn Lab Immunol. 1997;4:483-486
52. Lazzarotto T, Spezzacatena P, Pradelli P, Abate DA, Varani S, Landini MP. Avidity of immunoglobulin G directed against human cytomegalovirus during primary and secondary infections in immunocompetent and immunocompromised subjects. Clin Diagn Lab Immunol. 1997;4: 469-473
53. Lazzarotto T, Varani S, Spezzacatena P, Gabrielli L, Pradelli P, Guerra B, et al. Maternal IgG avidity and IgM detected by blot as diagnostic tools to identify pregnant women at risk of transmitting cytomegalovirus. Viral Immunol. 2000;13:137-141
54. Lazzarotto T, Galli C, Pulvirenti R, Rescaldani R, Vezzo R, La Gioia A, et al. Evaluation of the Abbott AxSYM cytomegalovirus (CMV) immunoglobulin M (IgM) assay in conjunction with other CMV IgM tests and a CMV IgG avidity assay. Clin Diagn Lab Immunol. 2001;8:196-198
55. Lazzarotto T, Gabrielli L, Lanari M, Guerra B, Bellucci T, Sassi M, et al. Congenital cytomegalovirus infection: recent advances in the diagnosis of maternal infection. Hum Immunol. 2004;65:410-415
56. Lazzarotto T, Guerra B, Lanari M, Gabrielli L, Landini MP. New advances in the diagnosis of congenital cytomegalovirus infection. J Clin Virol. 2008;41:192-197
57. Liesnard C, Donner C, Brancart F, Gosselin F, Delforge ML, Rodesch F. Prenatal diagnosis of congenital cytomegalovirus infection: prospective study of 237 pregnancies at risk. Obstet Gynecol. 2000;95:881-888
58. Lipitz S, Yagel S, Shalev E, Achiron R, Mashiach S, Schiff E. Prenatal diagnosis of fetal primary cytomegalovirus infection. Obstet Gynecol. 1997;89:763-767
59. Lukacsi A, Tarodi B, Endreffy E, Babinszki A, Pal A, Pusztai R. Human cytomegalovirus gB genotype 1 is dominant in congenital infections in South Hungary. J Med Virol. 2001;65:537-542
60. MacéM, Sissoeff L, Rudent A, Grangeot-Keros L. A serological testing algorithm for the diagnosis of primary CMV infection in pregnant women. Prenat Diagn. 2004;24: 861-863 (Pubitemid 39576798)
61. Maine GT, Lazzarotto T, Landini MP. New developments in the diagnosis of maternal and congenital CMV infection. Expert Rev Mol Diagn. 2001;1:19-29.
62. Malinger G, Lev D, Zahalka N, Ben Aroia Z, Watemberg N, Kidron D, et al. Fetal cytomegalovirus infection of the brain: the spectrum of sonographic findings. AJNR Am J Neuroradiol. 2003;24:28-32.
63. Malm G, Engman ML. Congenital cytomegalovirus infections. Semin Fetal Neonatal Med. 2007;12:154-159
64. McCarthy M, Auger D, Whittemore SR. Human cytomegalovirus causes productive infection and neuronal injury in differentiating fetal human central nervous system neuroepithelial precursor cells. J Hum Virol. 2000;3:215-228
65. Mocarski ES, Courcelle CT. Cytomegaloviruses and their replication. Fields Virology, 4th edition. Boston: Lippincott Williams & Wilkins. 2001;2629-2673
66. Mosca F, Pugni L. Cytomegalovirus infection: the state of the art. J Chemother. 2007;19 (Suppl 2):46-48
67. Moxley K, Knudtson EJ. Resolution of hydrops secondary to cytomegalovirus after maternal and fetal treatment with human cytomegalovirus hyperimmune globulin. Obstet Gynecol. 2008;111:524-526
68. Müller A, Eis-Hübinger AM, Brandhorst G, Heep A, Bartmann P, Franz AR. Oral valganciclovir for symptomatic congenital cytomegalovirus infection in an extremely low birth weight infant. J Perinatol. 2008;28:74-76
69. Murph JR, Souza IE, Dawson JD, Benson P, Petheram SJ, Pfab D, et al. Epidemiology of congenital cytomegalovirus infection: maternal risk factors and molecular analysis of cytomegalovirus strains. Am J Epidemiol. 1998;147:940-947
70. Nankervis GA, Kumar ML, Cox FE, Gold E. A prospective study of maternal cytomegalovirus infection and its effect on the fetus. Am J Obstet Gynecol. 1984;149:435-440
71. Natali A, Valcavi P, Medici MC, Dieci E, Montali S, Chezzi C. Cytomegalovirus infection in an Italian population: antibody prevalence, virus excretion and maternal transmission. New Microbiol. 1997;20:123-133
72. Nigro G, Adler SP, La Torre R, Best AM. Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med. 2005;353:1350-1362
73. Nigro G, Torre RL, Pentimalli H, Taverna P, Lituania M, de Tejada BM, et al. Regression of fetal cerebral abnormalities by primary cytomegalovirus infection following hyperimmunoglobulin therapy. Prenat Diagn. 2008;28: 512-517
74. Ornoy A, Diav-Citrin O. Fetal effect of primary and secondary cytomegalovirus infection in pregnancy. Repro Toxic. 2006;21:399-409.
75. Pass RF, Stagno S, Myers GJ, Alford CA. Outcome of symptomatic congenital cytomegalovirus infection: results of long-term longitudinal follow-up. Pediatrics 1980;66:758-762
76. Pass RF, Hutto C, Lyon MD, Cloud G. Increased rate of cytomegalovirus infection among day care center workers. Pediatr Infect Dis J. 1990;9:465-470
77. Pass RF, Boppana S. Cytomegalovirus In: Jeffries DJ, Hudson CN (Eds.). Viral infection in obstetrics and gynaecology. New York: Arnold, 1999;35-36
78. Pass RF. Cytomegalovirus infection. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, et al. (Eds). Field's virology, 4th edition. Philadelphia: Lippincott- Williams & Wilkins, 2001;2675-2705
79. Pass RF, Fowler KB, Boppana SB, Britt WJ, Stagno S. Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. J Clin Virol. 2006;35:216-220
80. Peckham CS, Stark O, Dudgeon JA, Martin JA, Hawkins G. Congenital cytomegalovirus infection: a cause of sensorineural hearing loss. Arch Dis Child. 1987;62:1233-1237
81. Picone O, Costa JM, Leruez-Ville M, Ernault P, Olivi M, Ville Y. Cytomegalovirus (CMV) glycoprotein B genotype and CMV DNA load in the amniotic fluid of infected fetuses. Prenat Diagn. 2004;24:1001-1006
82. Picone O, Costa JM, Leruez-Ville M, Ernault P, Olivi M, Ville Y. Cytomegalovirus (CMV) glycoprotein B genotype and CMV DNA load in the amniotic fluid of infected fetuses. Prenat Diagn. 2004;24:1001-1006
83. Picone O, Costa JM, Chaix ML, Ville Y, Rouzioux C, Leruez-Ville M. Human cytomegalovirus UL144 gene polymorphisms in congenital infections. J Clin Microbiol. 2005;43:25-29
84. Picone O, Simon I, Benachi A, Brunelle F, Sonigo P. Comparison between ultrasound and magnetic resonance imaging in assessment of fetal cytomegalovirus infection. Prenat Diagn. 2008;28:753-758
85. Preece PM, Blount JM, Glover J, Fletcher GM, Peckham CS, Griffiths PD. The consequences of primary cytomegalovirus infection in pregnancy. Arch Dis Child. 1983;58: 970-975
86. Ramsay ME, Miller E, Peckham CS. Outcome of confirmed symptomatic congenital cytomegalovirus infection. Arch Dis Child. 1991;66:1068-1069
87. Revello MG, Percivalle E, Gerna G. Immunoglobulin M to the membrane of uninfected fibroblasts in primary human cytomegalovirus infections. Microbiologica. 1986;9:127-138
88. Revello MG, Sarasini A, Zavattoni M, Baldanti F, Gerna G. Improved prenatal diagnosis of congenital human cytomegalovirus infection by a modified nested polymerase chain reaction. J Med Virol. 1998;56:99-103.
89. Revello MG, Zavattoni M, Baldanti F, Sarasini A, Paolucci S, Gerna G. Diagnostic and prognostic value of human cytomegalovirus load and IgM antibody in blood of congenitally infected newborns. J Clin Virol. 1999;14:57-66. (Pubitemid 29454638)
90. Revello MG, Zavattoni M, Furione M, Lilleri D, Gorini G, Gerna G. Diagnosis and outcome of preconceptional and periconceptional primary human cytomegalovirus infections. J Infect Dis. 2002;186:553-557
91. Revello MG, Gerna G. Pathogenesis and prenatal diagnosis of human cytomegalovirus infection. J Clin Virol. 2004;29:71-83. (Pubitemid 38121576)
92. Revello MG, Furione M, Zavattoni M, Tassis B, Nicolini U, Fabbri E, et al. Human cytomegaloviris (HCMV) DNAemia in the mother at amniocentesis as a risk factor for iatrogenic HCMV infection of the fetus. J Infect Dis. 2008;197:593-596
93. Ross DS, Victor M, Sumartojo E, Cannon MJ. Women's knowledge of congenital cytomegalovirus: results from the 2005 HealthStyles survey. J Womens Health (Larchmt). 2008;17:849-858
94. Ruellan-Eugene G, Barjot P, Campet M, Vabret A, Herlicoviez M, Muller G, et al. Evaluation of virological procedures to detect fetal human cytomegalovirus infection: avidity of IgG antibodies, virus detection in amniotic fluid and maternal serum. J Med Virol. 1996;50:9-15.
95. Saigal S, Lunyk O, Larke RP, Chernesky MA. The outcome in children with congenital cytomegalovirus infection. A longitudinal follow-up study. Am J Dis Child. 1982;136:896-901.
96. Schleiss MR, Mark R, Schleiss MD. Congenital Cytomegalovirus Infection: Update on management strategies. Curr Treat Options Neurol. 2008;10:186-192
97. Schmidt W, Yarkoni S, Jeanty P, Grannum P, Hobbins JC. Sonographic measurements of the fetal spleen: clinical implications. J Ultrasound Med. 1985;4:667-672
98. Senoh D, Hata T, Kitao M. Fetal liver length measurement does not provide a superior means for prediction of a small for gestational age fetus. Am J Perinatol. 1994;11: 344-347
99. Shibata M, Takano H, Hironaka T, Hirai K. Detection of human cytomegalovirus DNA in dried newborn blood filter paper. J Virol Methods. 1994;46:279-285
100. Stagno S, Pass RF, Cloud G, Britt WJ, Henderson RE, Walton PD, et al. Primary cytomegalovirus infection in pregnancy: incidence, transmission to fetus, and clinical outcome. J Am Med Assoc. 1986;256:1904-1908
101. Stagno S, Pass RF, Cloud G, Britt WJ, Henderson RE, Walton PD, et al. Primary cytomegalovirus infection in pregnancy: incidence, transmission to fetus, and clinical outcome. J Am Med Assoc. 1986;256:1904-1908
102. Stagno S. Cytomegalovirus. In: Remington JS, Klein JO (Eds.) Infectious diseases of the fetus and newborn infant, 5th edition. Philadelphia: Saunders, 2001;389-424.
103. Steinlin MI, Nadal D, Eich GF, Martin E, Boltshauser EJ. Late intrauterine cytomegalovirus infection: clinical and neuroimaging findings. Pediatr Neurol. 1996;15:249-253
104. Stronati M, Lombardi G, Di Comite A, Fanos V. Breastfeeding and cytomegalovirus infections. J Chemother. 2007;19 (Suppl 2):49-51.
105. Tookey PA, Ades AE, Peckham CS. Cytomegalovirus prevalence in pregnant women: the influence of parity. Arch Dis Child. 1992;67:779-783
106. Vauloup-Fellous C, Ducroux A, Couloigner V, Marlin S, Picone O, Galimand J, et al. Evaluation of cytomegalovirus (CMV) DNA quantification in dried blood spots: retrospective study of CMV congenital infection. J Clin Microbiol. 2007;45:3804-3806
107. Ville Y. The megalovirus. Ultrasound Obstet Gynecol. 1998;12:151-153
108. Weiner CP. The role of cordocentesis in fetal diagnosis. Clin Obstet Gynecol. 1988;31:285-292
109. Yow MD, Lakeman AD, Stagno S, Reynolds RB, Plavidal FJ. Use of restriction enzymes to investigate the source of a primary cytomegalovirus infection in a pediatric nurse. Pediatrics. 1982;70:713-716
110. Yow MD, Williamson DW, Leeds LJ, Thompson P, Woodward RM, Walmus BF, et al. Epidemiologic characteristics of cytomegalovirus infection in mothers and their infants. Am J Obstet Gynecol. 1988;158:1189-1195
111. Zalel Y, Gilboa Y, Berkenshtat M, Yoeli R, Auslander R, Achiron R, et al. Secondary cytomegalovirus infection can cause severe fetal sequelae despite maternal preconceptional immunity. Ultrasound Obstet Gynecol. 2008;31:417-420